你即將離開本站

並前往https://www.annalsofoncology.org/article/S0923-7534(19)32696-1/fulltext

Optimising TNFRSF agonism and checkpoint blockade with a ...

The generation of a bispecific agonist of CD137 following PD-L1 crosslinking allows a greater therapeutic window with improved safety and efficacy.

確定！ 回上一頁

查詢 「Agonism」的人也找了：

  1. agonism中文
    2.
  2. agonist and antagonist中文
    3.
  3. Inverse agonism
    4.
  4. Antagonist
    5.
  5. Agonist and antagonist
    6.
  6. Agonist vs antagonist
    7.
  7. agonistic中文
    8.
  8. Agonistic
    9.